🇺🇸

Broad Market

· monthly

US Pre-Market SEC Filings Roundup — October 02, 2026

This overnight filing cycle reveals a market bifurcated between aggressive capital deployment and strategic retrenchment. A dominant theme is the surge in M&A and capital allocation, with CareTrust REIT executing a landmark £1.1B UK care home acquisition and Flowco Holdings closing a $113M energy services deal, both raising full-year guidance. Conversely, a wave of insider selling—including a $2.95M disposal by Alto Neuroscience's CFO and a $2.62M sale by Marvell Technology's President—signals potential conviction gaps at the executive level. Period-over-period data highlights acute distress in the pet sector, with Dogness International reporting a net loss of $27.6M, widening from a $5.1M loss, while NIO's vehicle deliveries declined 3.7% YoY despite a QoQ improvement. The most critical development is the proposed going-private of Utz Brands at a 91% premium, offering a clear arbitrage opportunity, while the complete exit of GIC from Claritev Corp and a forced EGM at Scully Royalty point to underlying governance and strategic shifts. The overall picture is one of high-velocity capital rotation, where acquirers are rewarded and laggards face intensified insider skepticism.

32 high priority 18 medium 50 total filings
· daily

US Material Events SEC 8-K Filings — October 01, 2026

The 50 filings from October 1, 2026, reveal a market sharply bifurcated between aggressive capital deployment and acute financial distress. A wave of transformative M&A and strategic investments is concentrated in the industrial and technology sectors, with Inseego, Liquidity Services, and CenterPoint Energy executing deals that will fundamentally reshape their competitive landscapes. Concurrently, a cluster of micro-cap and distressed companies, including Americas Carmart, Transcode Therapeutics, and Sadot Group, are navigating liquidity crises, going-concern warnings, and complex, contingent financing structures. The period-over-period data, while limited in this filing set, points to a clear trend of companies using equity and debt capital markets to fund growth (Pyxis, Sagimet, Runway Growth) while others are forced into dilutive or risky financing to survive. Insider activity is sparse but notable for its absence in several distressed situations, and forward-looking statements highlight a calendar packed with Phase 3 trial catalysts, merger completion dates, and critical waiver deadlines that will define the next quarter's winners and losers.

50 high priority 50 total filings
· daily

Global High-Priority Regulatory Events — October 01, 2026

This digest covers 50 high-priority market events from US SEC filings, dominated by a wave of delistings (10+ companies), insolvencies, and M&A completions. The most critical theme is the acceleration of small-cap and SPAC delistings, with 7 companies formally removed from Nasdaq/NYSE in a single week, signaling a severe liquidity and compliance crisis for micro-cap equities. M&A activity is bifurcated: large-scale strategic deals (CenterPoint's $2.62B divestiture, Gentherm/Modine Reverse Morris Trust) are closing successfully, while several SPAC mergers (Ripple/Evernorth, REEcycle) remain contingent on shareholder approvals. A notable cluster of insider-driven defaults and insolvencies in Indian markets (Siti Networks, SecureKloud) highlights ongoing stress in that jurisdiction. The aggregate period-over-period data reveals a clear pattern of asset sales being used to shore up balance sheets (Ashford Hospitality, CenterPoint) while companies like Getty Images and 5E Advanced Materials face existential liquidity threats. The key takeaway for investors is to avoid catching a falling knife in delisting micro-caps and to focus on the high-conviction, value-creating M&A where insiders have skin in the game.

50 high priority 50 total filings
· daily

US SEC Filings Daily Market Digest — October 01, 2026

Today's US market digest reveals a bifurcated landscape: energy and biotech sectors show strong momentum with high-impact catalysts, while financial distress signals emerge in several small caps. Magnolia Oil & Gas's post-acquisition production surge and TotalEnergies' multi-project expansion highlight energy sector growth, while Monte Rosa's Phase 1 data and PolyPid's regulatory progress underscore biotech upside. Conversely, Americas Carmart faces potential restructuring, Transcode Therapeutics triggered a convertible note prepayment, and Pyxis Oncology's funding runway is contingent on warrant exercise. Insider activity is mostly routine (director awards), but notable buys in ASP Isotopes and MFS Municipal Income Trust contrast with sales in Adlai Nortye. Capital allocation trends show a mix of ATM offerings (Chesapeake Utilities), buybacks (Magnolia), and M&A (NSTS Bancorp merger completion). Key upcoming catalysts include PolyPid's PDUFA date (Nov 28), Magnolia's Q3 earnings, and multiple Phase 2 trial initiations in H1 2027.

38 high priority 12 medium 50 total filings
· daily

Global High-Priority Regulatory Events — September 30, 2026

The September 30, 2026 filing set is dominated by event-driven situations: a high-profile healthcare M&A (Grindr/Freddie), a major retail bankruptcy (prearranged Chapter 11 with $685M debt elimination), and a wave of SPAC business combinations and delistings. Period-over-period data reveals strong growth in healthcare tech (Freddie's 62% YoY revenue growth) and continued distress in retail/energy. Insider activity is sparse but notable in the SPAC space. The overall theme is capital reallocation: from distressed assets to high-growth healthcare, with significant regulatory and event risk. Key opportunities lie in Grindr's strategic pivot, TAE's fusion energy potential, and the distressed debt recovery in the retail bankruptcy. Risks are concentrated in the high number of going-concern warnings, regulatory actions, and the dilutive nature of SPAC deals.

50 high priority 50 total filings
· daily

US SEC Filings Daily Market Digest — September 30, 2026

Today's digest reveals a market bifurcated between AI-driven growth stories (e.g., **Fortrea**, **Repligen**) and value-trap financials (e.g., **Chiba Bank**). M&A activity is robust, with three significant transactions (Fortrea, Repligen, AIRE) signaling consolidation, but regulatory and shareholder approval risks are elevated. Insider activity is mixed: **Silvercrest** insider buying suggests confidence, while **Hennessy** insider dilution and **Nova Minerals** going concern flag caution. Key themes: margin compression across industrials, China regulatory overhang, and a shift toward shareholder returns via buybacks over dividends. Watch for **Repligen** shareholder vote (Oct 5) and **Fortrea** regulatory clearances as near-term catalysts.

24 high priority 26 medium 50 total filings
· daily

US Material Events SEC 8-K Filings — September 29, 2026

The digest captures a dynamic period for the covered universe, marked by significant capital markets activity (debt raises, M&A), a clear pivot towards data centers and AI infrastructure, and notable governance changes. Key themes include aggressive balance sheet management (leverage up for M&A, down for others), a flurry of FDA-related news, and a shift in capital allocation towards share repurchases. While several companies are executing on high-growth strategies, the market is also pricing in execution risks, as seen in the wide range of outcomes from FDA decisions and the volatility in the solar and biotech sectors.

50 high priority 50 total filings
· daily

Global High-Priority Regulatory Events — September 29, 2026

The digest for September 29, 2026, is dominated by two major take-private transactions: the $6.3 billion acquisition of Global Business Travel Group (Amex GBT) by Long Lake Management and the $10.50/share tender offer for ACV Auctions by Copart, both of which are nearing completion. A significant theme is the ongoing stress in the SPAC market, with Bayview Acquisition Corp facing final delisting after failing to close a deal, while others like Constellation Acquisition Corp I continue to burn through extension periods. On the regulatory front, the Adani Group's consolidation of its cement businesses (ACC and Ambuja Cements) received overwhelming shareholder approval, marking a major strategic move. Insider activity is notably absent from these filings, but capital allocation actions, such as the tender offers by Golub Capital and PGIM Private Credit funds, signal a focus on shareholder returns in the private credit space. The period-over-period data reveals a stark contrast between the successful, high-premium takeovers and the struggling SPACs facing liquidation, highlighting a bifurcated market for event-driven strategies.

50 high priority 50 total filings
· daily

US SEC Filings Daily Market Digest — September 29, 2026

Today's filings reveal a bifurcated market: capital is flowing aggressively into healthcare innovation (Summit Therapeutics' $2B AstraZeneca investment, HUTCHMED's NDA submission) and nuclear/uranium plays (Uranium Energy's 157% QoQ production surge, Hennessy Capital's $1B SPAC merger with ONE Nuclear), while traditional industrials face restructuring headwinds (Westlake's $205M plant closure, Copart's flat revenue). Insider activity is mixed: Conifer Management aggressively accumulated Group 1 Automotive shares ($80.5M in September), while IFC reduced Lesaka Technologies holdings below 5%. SPAC activity remains elevated with Quartzsea seeking extension and Futurewave announcing a $400M merger. Small-cap distress persists with Bakhu Holdings (cash at $2K) and VIP Play (negative equity of $40M). Period-over-period trends highlight ChipMOS's 33% revenue growth and 118% profit surge, contrasting with Bakhu's deepening losses and Copart's stagnant top line. The overarching theme is selective capital deployment favoring high-growth biotech and energy transition, while value-oriented insider buying in auto retail suggests a contrarian opportunity.

34 high priority 16 medium 50 total filings
· monthly

US Pre-Market SEC Filings Roundup — September 29, 2026

This overnight filing cycle reveals a market bifurcated between aggressive corporate transformation and persistent financial distress. The most significant theme is a wave of high-value M&A and strategic investments, including AAR Corp's $4.0 billion acquisition of MRO Holdings, Summit Therapeutics' $2.0 billion partnership with AstraZeneca, and Sangoma Technologies' $204 million take-private. These deals signal strong conviction in aerospace, biotech, and enterprise tech sectors. Conversely, the materials and energy sectors show a stark contrast: Uranium Energy Corp is executing a successful turnaround with surging production and a strong balance sheet, while Westlake Corp is shuttering a major European PVC plant, incurring $205 million in charges. Financial health is a key differentiator; companies like UEC and AAR are leveraging strong balance sheets for growth, while distressed entities like Bakhu Holdings, VIP Play, and Singularity Future Technology are filing late reports with worsening deficits and near-zero cash positions. Insider activity is limited but notable, with a director at C1 Fund making a small open-market purchase, offering a faint positive signal in an otherwise quiet period for management transactions. The digest is dominated by capital allocation events (M&A, buybacks, dividends) and regulatory filings, with a clear undercurrent of companies either scaling up aggressively or facing existential liquidity challenges.

27 high priority 23 medium 50 total filings
· daily

US Material Events SEC 8-K Filings — September 28, 2026

This digest of 50 SEC filings from September 28, 2026, reveals a market in active transition, dominated by high-value M&A and significant capital market maneuvers. The most material events are three major acquisitions: the $2.34B Slate Grocery REIT acquisition by Brixmor/Everview, the $663.7M take-private of Lifecore Biomedical by Webster Equity Partners, and the $587M SPAC merger of Astro Digital with Proem Acquisition Corp. I. A clear sector theme is the aggressive deployment of capital in the energy and infrastructure space, highlighted by FTAI Infrastructure's $255M crude oil asset acquisition and Hut 8 Corp.'s $1.07B credit facility for AI data centers. Conversely, several companies are showing signs of distress, with Cambium Networks entering administration, and Hepion Pharmaceuticals and Origin Tea both switching auditors after receiving going-concern warnings. Insider activity is limited in these filings, but the prevalence of CFO departures (at Matternet, Jasper Therapeutics, Gain Therapeutics) and the appointment of CEOs as interim CFOs is a notable risk signal. The forward-looking data provides a clear catalyst calendar for Q4 2026 and Q1 2027, with several major deal closings and regulatory decisions expected. Overall, the market is rewarding scale and strategic positioning in high-growth sectors like AI infrastructure and energy logistics, while punishing companies with weak fundamentals or execution failures.

50 high priority 50 total filings
· daily

Global High-Priority Regulatory Events — September 28, 2026

This digest covers 42 filings from September 28, 2026, dominated by a wave of SPAC business combinations (Astro Digital, GOWell, REDLattice, EigenQ, NorthStar) and voluntary delistings (Sunoco, USA Compression, Energy Transfer LP preferred units), signaling a major restructuring of public market exposure. A significant theme is the consolidation in the Indian cement sector, with Orient Cement's amalgamation into Ambuja Cements receiving overwhelming shareholder approval (97.83% and 99.98% respectively), though institutional dissent at Orient (35.81% against) highlights valuation concerns. Financial distress is evident in Cambium Networks' going-concern sale to Airspan and Nexalin Technology's precarious Nasdaq compliance deadline. Insider activity is limited but notable, with Beretta's partial tender offer for Sturm, Ruger & Co. (up to 25% stake) representing a strategic accumulation play. Period-over-period data reveals REDLattice's strong 29% YoY revenue growth and Astro Digital's 42% two-year CAGR, contrasting with Silicon Valley Acquisition Corp's widening net losses. The concentration of voluntary delistings from energy MLPs (Sunoco, USA Compression) suggests a strategic shift away from public markets, potentially due to tax or regulatory considerations.

42 high priority 42 total filings
· daily

US SEC Filings Daily Market Digest — September 28, 2026

Today's digest reveals a market bifurcated between high-stakes corporate actions and routine disclosures. The most critical developments cluster around several SPAC business combinations and delisting events, with GOWell Energy Technology's successful merger (backed by a $70M PIPE) and NOVAGOLD's transformative acquisition of Donlin Gold standing out as high-conviction catalysts. Conversely, the delisting of Platinum Analytics and the Nasdaq deficiency at Hub Cyber Security highlight acute distress in the micro-cap space. From a financial health perspective, period-over-period data shows a mixed picture: Armlogi's revenue declined 2.4% YoY while operating expenses surged 49.7%, contrasting with Kentucky First Federal Bancorp's impressive turnaround to a $1.9M net profit from a $1.7M loss. Insider activity is sparse but notable, with Hyperscale Data's Executive Chairman making small open-market purchases, while several On Holding AG directors had shares withheld for taxes, a routine non-discretionary event. The forward-looking catalyst calendar is dominated by the upcoming Wolfe Research Conference (Kinder Morgan) and a critical Nasdaq hearing for urban-gro on October 6th. Overall, the data suggests a 'risk-on' environment for select special situations and a cautious stance on companies with deteriorating fundamentals and regulatory overhangs.

22 high priority 28 medium 50 total filings
· monthly

US Pre-Market SEC Filings Roundup — September 28, 2026

Overnight SEC filings reveal a market bifurcated between strategic growth moves and distress signals. Key themes include aggressive capital raises via SPAC mergers and ATMs (BOXABL, GOWell, Celularity), significant insider buying at Hyperscale Data, and major guidance raises at Gray Media on political ad strength. Conversely, several companies face existential risks: Platinum Analytics and urban-gro face delisting, GEE Group has a governance scandal, and multiple micro-caps (Golden Star, Greenway) show severe liquidity distress. Period-over-period data shows mixed earnings: Kentucky First Federal and Invest Acquisition turned profitable, while Armlogi and Vantage Corp saw losses widen. The EV/battery space shows strategic realignment (NIO-Geely, Amprius government contract), while gold miners (NOVAGOLD, SSR) signal consolidation. Overall, the digest highlights high-alpha opportunities in distressed assets and strategic transactions, alongside significant downside risks in governance and liquidity.

22 high priority 28 medium 50 total filings
· daily

US Material Events SEC 8-K Filings — September 25, 2026

This batch of 50 filings reveals a market bifurcated between aggressive capital deployment and operational distress. A clear theme is the significant capital market activity, with several companies issuing substantial debt ($1B by DICK'S Sporting Goods, $2.28B by CleanSpark, C$1.5B by Sysco) to fund growth, acquisitions, or refinancing, signaling a 'growth-at-scale' mindset in sectors like data centers and retail. Conversely, a cluster of companies (SOBR Safe, Sadot Group, Feel The World) are in acute distress, marked by discontinued operations, auditor dismissals due to internal control weaknesses, and financial restatements, creating a stark 'haves vs. have-nots' landscape. Leadership transitions are widespread, with 10+ filings announcing C-suite or board changes, though most appear orderly. A notable positive outlier is Worthington Enterprises, which reported a 13% YoY sales increase driven by the booming data center liquid cooling market, while The Hartford Insurance Group realized a massive $497M pre-tax gain from a reinsurance commutation. The most actionable intelligence lies in tracking the execution of the large-scale debt-funded strategies and monitoring the distressed companies for potential restructuring or dissolution events.

50 high priority 50 total filings
· daily

Global High-Priority Regulatory Events — September 25, 2026

This digest covers 42 filings, predominantly centered on a wave of Nasdaq and NYSE delisting threats, insolvency proceedings, and SPAC activity. The most critical theme is the cluster of 8+ companies facing imminent delisting for failing to meet minimum bid price, market value, or equity requirements, signaling severe financial distress across small-cap and pre-revenue biotech/tech sectors. A secondary theme is the surge in Indian insolvency and open offer activity, including the NCLT approval of Dabur India's Sesa Care merger and the rejection of a settlement proposal for Vas Infrastructure, highlighting a bifurcation between successful restructuring and deadlocked resolutions. SPAC filings show mixed signals: while Paramount Skydance and NMP Acquisition Corp. advance their mergers, SilverBox Corp IV and Inflection Point Acquisition Corp. V have been delisted, underscoring the high failure rate in the de-SPAC pipeline. Tender offers from closed-end funds like BlackRock Alpha Strategies and Ares Strategic Income Fund indicate a trend of managed liquidity events, though low take-up rates in several A&Q funds suggest limited investor appetite. The overall sentiment is negative, with 15+ filings carrying negative sentiment and materiality scores of 8/10 or higher, concentrated in delisting and insolvency risks.

42 high priority 42 total filings
· daily

US SEC Filings Daily Market Digest — September 25, 2026

Today's filings reveal a market bifurcated between high-stakes corporate actions (mergers, asset sales, activist stakes) and routine governance updates. Key themes include significant M&A and restructuring activity (VerifyMe/OpenWorld merger, Titan International's $285M divestiture, Quality Industrial's complex share exchange), activist investor positioning (Jewett Cameron 13D filing), and leadership transitions at major firms (Monster Beverage, Circle, Nextdoor). Period-over-period data is sparse, but forward-looking statements highlight major catalysts: Elroy Air's $175M PIPE and Army contract, Tamboran's first gas sales, and Pulmatrix's reverse merger. Insider activity is mostly routine grants, but a notable director sale at Cypherpunk Technologies ($662K) and a large insider award at Janus International ($750K retention RSUs) stand out. The overall sentiment is cautiously optimistic, with several 'mixed' filings reflecting the uncertainty inherent in pending deals and restructurings.

42 high priority 8 medium 50 total filings
· monthly

US Pre-Market SEC Filings Roundup — September 25, 2026

The overnight filing batch (Sep 24-25, 2026) reveals a market dominated by capital markets activity, with several SPAC business combinations and de-SPAC transactions progressing, alongside notable insider selling and a few strategic insider purchases. Key themes include significant insider selling in small/mid-cap names (Aspen Aerogels, Mineralys Therapeutics, Omeros) and a major block trade exit by Wood River Capital from Aspen Aerogels, signaling potential sector rotation or liquidity needs. On the positive side, several companies are executing strategic pivots into high-growth sectors like space infrastructure (Non Invasive Monitoring Systems/Gravitics) and autonomous drones (Elroy Air), while others are strengthening governance (BOXABL, Clover Health). Capital allocation trends show a mix of aggressive buybacks (Lloyds Banking Group completing a £1.75B program) and dilutive financing (Black Hawk Acquisition's $200M SEPA). The period-over-period data is limited in this batch, but forward-looking statements and insider activity provide actionable signals for the upcoming trading session.

30 high priority 20 medium 50 total filings
· daily

US Material Events SEC 8-K Filings — September 24, 2026

This batch of 50 filings reveals a market sharply bifurcated between aggressive capital deployment and defensive refinancing. Major themes include a surge in large-scale, strategic M&A and partnerships (Akamai's $11.6B AI deal with Anthropic, Select Water's $700M acquisition, Elmet Group's $124.75M strategic stake) alongside a wave of debt capital markets activity as companies lock in long-term financing (Marriott's $5B revamp, Alexandria's $5B facility, Vistra's $1.5B note offering). A significant number of smaller-cap companies are resorting to dilutive financing (Jaguar Health, Patriot National, Glucotrack) or restructuring debt (DevvStream, Crypto Co), signaling a liquidity crunch in the lower end of the market. Governance changes were routine, but shareholder activism is visible at AMC Entertainment, where four key proposals failed despite overwhelming support, highlighting a structural governance issue. The data shows no uniform period-over-period trends, as most filings lacked financial statements, but the capital allocation patterns are stark: large caps are investing and refinancing, while small caps are fighting for survival.

50 high priority 50 total filings
· daily

Global High-Priority Regulatory Events — September 24, 2026

This intelligence digest covers 28 filings from September 24, 2026, dominated by corporate restructuring events (insolvencies, mergers, and delistings) across US and Indian markets. A clear theme is the acceleration of capital recycling through SPAC mergers (Black Hawk, Haymaker V, Live Oak VI, UY Scuti) and tender offers (Utah Medical, Ares Strategic, Beacon Topco, Vista Credit, Evanston Multi-Alpha), with aggregate capital deployment exceeding $500 million. The Indian insolvency landscape shows active resolution plan implementation (Rajeswari Infrastructure, Zicom Electronic Security, Jatalia Global Ventures) with significant shareholder dilution and capital restructuring. Delisting activity is elevated, with three Nasdaq delistings (Jasper Therapeutics, Waldencast, KLX Energy) and one voluntary NYSE delisting (Two Harbors Investment) on the same day, signaling potential distress or strategic repositioning. The banking sector shows consolidation momentum with First Bancorp's acquisition of First Carolina Bancshares valued at ~$1,228 per share. Insider activity is notably absent across most filings, with only Utah Medical's insider group owning 7.9% of shares in a tender offer, providing limited management conviction signals. Forward-looking data points to a catalyst-rich October 2026 with multiple shareholder meetings, open offer deadlines, and merger completion timelines.

28 high priority 28 total filings